CIK 1964437
Long positions in SEC Section 13(f) securities (US-listed stocks, ADRs and ETFs), largest first · Δ vs 2025-Q4. A lagged quarterly snapshot (filed ≤45 days after quarter-end); excludes shorts, options, cash, and shares listed only on non-US exchanges — foreign companies held via a US listing or ADR (e.g. Alibaba, TSMC) ARE included.
As filed = each book applied at its quarter-end (what the reported book did) · As copyable = applied at its statutory 45-day filing deadline (what a 13F follower could have earned).
Computing…
Hypothetical modeled performance constructed with hindsight — not actual results, and not indicative of future results. See the Disclaimer.
| Industry group | Weight | Names |
|---|---|---|
| Pharmaceuticals & Biotechnology | 85.54% | 18 |
| Unclassified | 8.63% | 2 |
| Health Care Providers & Services | 5.83% | 1 |
| # | Ticker | Name | Sector | Weight |
|---|---|---|---|---|
| 1 | ALMS | ALUMIS INC. | Health Care | 12.77% |
| 2 | AMLX | Amylyx Pharmaceuticals, Inc. | Health Care | 10.95% |
| 3 | ABVX | Abivax S.A. | Health Care | 10.94% |
| 4 | PCVX | Vaxcyte, Inc. | Health Care | 8.68% |
| 5 | PHVS | PHARVARIS N V | Unclassified | 6.15% |
| 6 | IMMX | Immix Biopharma, Inc. | Health Care | 6.09% |
| 7 | CELC | Celcuity Inc. | Health Care | 5.83% |
| 8 | JAZZ | Jazz Pharmaceuticals plc | Health Care | 5.58% |
| 9 | IRON | Disc Medicine, Inc. | Health Care | 5.21% |
| 10 | XFOR | X4 Pharmaceuticals, Inc | Health Care | 4.83% |
19/21 names classified · sector 91.4% of weight · industry 91.4% · mkt cap 80.4%; unclassified names shown, never dropped.
Sector is classified on each name's CURRENT fundamentals, not point-in-time — apparent sector drift can reflect the market re-rating a holding, not a manager trade. 13F is a lagged quarterly snapshot of long positions in US-listed securities only — foreign companies held via a US listing or ADR ARE included, but shares listed only on non-US exchanges (plus shorts, options and cash) are not. Latest quarter: 91.4% of the book is sector-classified (unclassified names shown, never dropped).
Only 0% of book weight classified — the grid is NOT representative of the whole book.
Classified: 0.0% of book weight (0/21 names) · unclassified 100.0%: ALMS, AMLX, ABVX, PCVX, PHVS, IMMX, CELC, JAZZ, IRON, XFOR +11 more. Size: cap 70/20/10 bands; style: value/growth composite on our own metrics — not Morningstar's model.
No contribution data for this period.
| # | Security | Shares | Value | Weight | Δ QoQ |
|---|---|---|---|---|---|
| 1 | ALMSALUMIS INC | 3,202,075 | $71M | 12.8% | ADD 2% |
| 2 | AMLXAMYLYX PHARMACEUTICALS INC | 4,349,885 | $60M | 10.9% | TRIM −3% |
| 3 | ABVXABIVAX SA | 542,696 | $60M | 10.9% | TRIM −16% |
| 4 | PCVXVAXCYTE INC | 824,532 | $48M | 8.7% | ADD 3% |
| 5 | PHVSPHARVARIS N V | 1,201,402 | $34M | 6.1% | ADD 5% |
| 6 | IMMXIMMIX BIOPHARMA INC | 3,693,585 | $34M | 6.1% | ADD 23% |
| 7 | CELCCELCUITY INC | 281,904 | $32M | 5.8% | TRIM −11% |
| 8 | JAZZJAZZ PHARMACEUTICALS PLC | 162,961 | $31M | 5.6% | TRIM −34% |
| 9 | IRONDISC MEDICINE INC | 449,926 | $29M | 5.2% | ADD 51% |
| 10 | XFORX4 PHARMACEUTICALS INC | 6,456,646 | $27M | 4.8% | ADD 11% |
| 11 | COGTCOGENT BIOSCIENCES INC | 626,635 | $24M | 4.4% | TRIM −49% |
| 12 | MNPRMONOPAR THERAPEUTICS INC | 345,626 | $19M | 3.4% | ADD 6% |
| 13 | DYNDYNE THERAPEUTICS INC | 966,609 | $18M | 3.2% | TRIM −46% |
| 14 | IVVDINVIVYD INC | 10,949,084 | $14M | 2.6% | ADD 42% |
| 15 | CADLCANDEL THERAPEUTICS INC | 2,896,588 | $14M | 2.6% | NEW |
| 16 | OCSOCULIS HOLDING AG | 516,761 | $14M | 2.5% | HOLD |
| 17 | OVIDOVID THERAPEUTICS INC | 4,166,666 | $9M | 1.7% | ADD 67% |
| 18 | IKTINHIBIKASE THERAPEUTICS INC | 3,863,445 | $6M | 1.2% | HOLD |
| 19 | ZURAZURA BIO LTD | 739,960 | $4M | 0.8% | NEW |
| 20 | ANROALTO NEUROSCIENCE INC | 88,999 | $2M | 0.4% | NEW |
| 21 | MSLESATELLOS BIOSCIENCE INC | 350,000 | $2M | 0.4% | NEW |
| Security | 2024-Q4 | 2025-Q1 | 2025-Q2 | 2025-Q3 | 2025-Q4 | 2026-Q1 | Latest value |
|---|---|---|---|---|---|---|---|
| ALMSALUMIS INC | — | — | — | — | 3.1M | 3.2M | $71M |
| AMLXAMYLYX PHARMACEUTICALS INC | 889K | 2.4M | 3.3M | 4.6M | 4.5M | 4.3M | $60M |
| ABVXABIVAX SA | 653K | 553K | 622K | 801K | 649K | 543K | $60M |
| PCVXVAXCYTE INC | 204K | 232K | 544K | 788K | 799K | 825K | $48M |
| PHVSPHARVARIS N V | — | — | — | 886K | 1.1M | 1.2M | $34M |
| IMMXIMMIX BIOPHARMA INC | — | — | — | — | 3.0M | 3.7M | $34M |
| CELCCELCUITY INC | 1.1M | 1.1M | 1.2M | 474K | 317K | 282K | $32M |
| JAZZJAZZ PHARMACEUTICALS PLC | — | — | 207K | 301K | 248K | 163K | $31M |
| IRONDISC MEDICINE INC | 509K | 518K | 396K | 341K | 298K | 450K | $29M |
| XFORX4 PHARMACEUTICALS INC | — | — | — | — | 5.8M | 6.5M | $27M |
| COGTCOGENT BIOSCIENCES INC | 1.5M | 1.5M | 2.3M | 2.0M | 1.2M | 627K | $24M |
| MNPRMONOPAR THERAPEUTICS INC | — | — | — | 155K | 326K | 346K | $19M |
| DYNDYNE THERAPEUTICS INC | — | — | 1.5M | 2.7M | 1.8M | 967K | $18M |
| IVVDINVIVYD INC | — | — | — | — | 7.7M | 10.9M | $14M |
| CADLCANDEL THERAPEUTICS INC | — | — | — | — | — | 2.9M | $14M |
Shares reported each quarter by the largest current holdings. Green = added vs the prior filing of that name, red = trimmed, grey = roughly held; a dash is a quarter with no 13F on file (a gap is skipped, not read as an exit). 13F is filed up to 45 days after quarter-end. Up to 40 quarters (10 years) available — use the selector above.
Where this firm's principals came from and which firms its alumni went on to found.
